TABLE 4.
Variants with potential NS3 and NS5A resistance-associated amino acid positions
Patient IDa | GTb | RAV(s) for each position in proteinc: |
|||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
NS3 |
NS5A |
||||||||||||||||||||
V36any | F43any | T54any | V55any | Q80any | S122R | R155any | A156any | D168any | I170A/T/L | L175L | K24G/N/R | M28A/G/T | Q30any | L31any | P32L | S38F | H58D | A92K/L | Y93any | ||
A | 1a | L | |||||||||||||||||||
B | 1b | R | L/M | ||||||||||||||||||
C | 2a | L | G | L | K | M | |||||||||||||||
D | 2b | L | G | R | L | K | |||||||||||||||
E | 2b | L | G | R | L | K | M | ||||||||||||||
F | 2c | L | G | R | L | K | F | ||||||||||||||
G | 2c | L | G | R | L | K | M | ||||||||||||||
H | 2j | L | G | R | L | K | M | ||||||||||||||
I | 3a | L | Q | L | A | ||||||||||||||||
J | 3i | L | Q | L | K | ||||||||||||||||
K | 4a | L | L | S | M | ||||||||||||||||
L | 4d | L | L | R | M | ||||||||||||||||
M | 5a | L | K | L | T | ||||||||||||||||
N | 6a | K | R | T | |||||||||||||||||
O | 6a | K | R | T | |||||||||||||||||
P | 6e | S | S | ||||||||||||||||||
Q | 6j | A | T |
ID, identification.
GT, genotype.
Substitutions show positions in NS3 and NS5A gene with corresponding wild-type amino acid first (from 1a H77 reference genome) and the amino acid(s) associated with second. For each patient, the presence of amino acids associated with resistance is shown in the table. Blank cells indicate identical amino acid as that of 1a wild type, which has not been associated with resistance.